An elevated PSA level in the blood may indicate prostate cancer but does not allow for a definitive diagnosis. Where there is ...

An imaging test could safely halve the number of people who need a biopsy for suspected prostate cancer following inconclusive or reassuring results from an MRI scan, new research has found. Findings ...

Add Yahoo as a preferred source to see more of our stories on Google. The scan works by using a molecule that binds to prostate cancer cells, causing them to appear as bright spots on imaging A scan ...

The scan found 91 percent of dangerous tumors and correctly cleared most men who didn’t need a biopsy at all.

An elevated PSA level in the blood may indicate prostate cancer, but does not yet allow for a definitive diagnosis.

Prostate-specific membrane antigen (PSMA)-PET/CT imaging identified metastatic prostate cancer in almost half of high-risk cases missed by conventional imaging, a retrospective analysis showed.

While these advanced imaging tools save lives by detecting injuries and illness, mounting evidence suggests they may come with long-term consequences that patients need to understand before agreeing ...

More than 100,000 future cancer cases were projected to result from the 93 million CT examinations performed in 2023, according to a study published April 14 in JAMA Internal Medicine. Low-dose CT ...

About 40% of cancers among Americans can be attributed to potentially modifiable factors such as smoking, drinking, obesity, and physical inactivity. If a widely reported study from earlier this year ...